Newtopia is emboldened by our immediate growth prospects based on three exciting developments in the market: Growth of GLP-1s opens a huge market for Newtopia to demonstrate sustainability and ROI. Rise of Health AI and next-gen clinical discovery requires Newtopia's novel data and capabilities. Expansion opportunities with Heartland Whole Health Institute based on Newtopia's best-ever reported outcomes. TORONTO, May 23, 2024 /CNW/ - Newtopia Inc. ("Newtopia" or the "Company") (TSXV:NEWU) (OTCQB:NEWUF), a tech-enabled whole health platform creating sustainable habits that prevent, slow, and reverse chronic disease, today announced its fourth quarter, fiscal 2023 and first quarter 2024 financial results, operational highlights and filing of its annual financial statements. These results pertain to the three months and year ended December 31, 2023 as well as the three months ended March 31, 2024. All amounts are expressed in Canadian dollars, unless otherwise noted. The foregoing is a summary of selected information for the years ended December 31, 2023 and 2022 in addition to the quarter ending March 31, 2024 and is qualified in its entirety by, and should be read in conjunction with, Newtopia's consolidated financial statements and management discussion and analysis for the respective periods. The Company expects such financial statements to be filed on May 28, 2024 and will be available on SEDAR+ at www.sedarplus.com. Fourth Quarter 2023 Financial Highlights (vs. Q4 2022): Revenue of $2.3 million, as compared to $3.1 million. Gross profit margin1 of 63%, as compared to 65%. Full Year 2023 Financial Highlights (vs. 2022): Revenue of $9.8 million, as compared to $11.2 million. Gross profit margin1 of 62%, as compared to 53%. First Quarter 2024 Financial Highlights (vs. Q1 2023): Revenue of $1.8 million, as compared to $2.6 million. Gross profit margin1 of 50%, as compared to 60%. "We see three distinct and exciting strategic areas of opportunity for growth for Newtopia including: (1) expanding our key innovation partnerships, such as Heartland Whole Health Institute; (2) combining Newtopia's proven habit change platform with GLP-1 drugs for obesity and type 2 diabetes; and (3) partnering with health AI and clinical discovery innovators to improve our collective ability to deliver best in breed outcomes that prevent, reverse and slow chronic disease, said Jeff Ruby, Founder and CEO of Newtopia. "Throughout 2023 and in early 2024, we've made great strides in reducing our cost to serve participants while at the same time increasing our operational efficiencies – all while maintaining and improving our industry leading engagement and whole health outcomes. In the first quarter of 2024, we delivered our best ever outcomes for the first two cohorts of our innovative health coaching project with the Heartland Whole Health Institute in Northwest Arkansas," said Jeff Ruby, Founder and CEO of Newtopia. "While we made great progress, revenue in Q4 2023 and Q1 2024 was impacted by a change with a long-standing incentive program at one of our largest clients. Fortunately, our relationship with the client remains incredibly strong, and commencing in Q2, we are working with them on strengthening new registrations through market expansion and the re-introduction of Newtopia to existing markets," Ruby concluded. Fourth Quarter 2023 Financial Results Revenue for the three months ended December 31, 2023, was $2.3 million, a decrease of 25% compared to $3.1 million in the prior-year period. This decline was driven by a change in a multi-year contract renewal. Actions are underway with this client to recoup lost volume associated with this change. Enrollment fee revenue, or revenue from Welcome Kit sales, totaled 8% of revenue for the quarter. Gross profit for the fourth quarter 2023 totaled $1.5 million, as compared to $2.1 million in the prior-year period. Gross profit is comprised of Newtopia's revenue less direct expenses, which include the cost of Welcome Kits sold to new participants as well as labor costs associated with hiring and training of the Company's coaching team of Inspirators and amortization of intangibles. As a percentage of revenue, core gross profit totaled 63% compared to 65% in the prior-year period. Adjusted operating expenses2 for the three months ended December 31, 2023, totaled $1.6 million, compared to $2.8 million in the prior-year period. For the fourth quarter, the Company was roughly EBITDA neutral with an adjusted operating loss3 of $66,000, compared with an adjusted operating loss of $714,000 in the prior-year period. The Company ended the fourth quarter 2023 with approximately $0.4 million in cash, with additional access to their revolving line of credit with a Canadian Schedule 1 bank. Of note, the Company finalized the refinancing of $2.5 million debt in October 2023. Full Year 2023 Financial Results Revenue for the full year ended December 31, 2023, was $9.8 million, a decrease of 12% compared to $11.2 million in the prior year. Engagements totaled 125,000 for the full year, a decrease of 16% year-over-year. Enrollment fee revenue, or revenue from Welcome Kit sales, totaled 12% of revenue for the year. Gross profit for the year on an apples-to-apples basis totaled $6.1 million, consistent with 2022. As a percentage of revenue, gross profit totaled 62%, up from the prior year of 53%. Adjusted operating expenses2 for the year totaled $7.3 million, as compared to $11.8 million in the prior year. For the full year ended December 31, 2023, the Company had an adjusted operating loss3 of $1.2 million, compared with a loss of $5.7 million in 2022. First Quarter 2024 Financial Results Revenue for the three months ended March 31, 2024 was $1.8 million, a decrease of 31% compared to $2.6 million in the prior-year period. This decline was driven by the aforementioned change made by a client with a long-standing incentive program. Enrollment fee revenue, or revenue from Welcome Kit sales, totaled 17% of revenue for the quarter. Gross profit for the first quarter 2024 totaled $0.9 million, as compared to $1.6 million in the prior-year period. Gross profit is comprised of Newtopia's revenue less direct expenses, which include the cost of Welcome Kits sold to new participants as well as labor costs associated with hiring and training of the Company's coaching team of Inspirators. As a percentage of revenue, gross profit totaled 50%, compared to 60% in the prior-year period. Adjusted operating expenses2 for the three months ended March 31, 2024, totaled $1.6 million, compared to $2.3 million in the prior-year period. For the first quarter, the Company posted an adjusted operating loss3 of $667,000, compared with an adjusted operating loss of $727,000 in the prior-year period. The Company ended the first quarter 2024 with $0.33 million in cash, with additional access to their revolving line of credit with a Canadian Schedule 1 bank. Of note, the Company finalized a bridge equity round of $0.7 million in Feb 2024. 2024 Outlook Despite a challenging macro environment, the Company remains bullish regarding the outlook of the healthcare industry in 2024. Newtopia will continue to execute on its pipeline to return to EBITDA positive. Conference Call The Company will host a conference call May 23rd at 5:00 p.m. Eastern Time to discuss these results in further detail. To access the conference call, please dial (800) 717-1738 (U.S.) or (646) 307-1865 (International) 10 minutes prior to the start time and reference Conference ID number 76573. The call will also be available via live webcast on the investor relations portion of the Company's website located at investor.newtopia.com. A replay of the conference call will be available through June 5, 2024, which can be accessed by dialing (844) 512-2921 (U.S.) or (412) 317-6671 (International) and entering the passcode 11155888. The webcast will also be archived on the Company's website. About Newtopia Newtopia is a personalized whole health platform helping people create positive lifelong habits that prevent, slow, or reverse chronic disease while reducing healthcare costs. The platform leverages genetic, social, and behavioral insights to create individualized prevention programs with a focus on metabolic disease, diabetes, mental health challenges, hypertension, weight management and musculoskeletal disorders. With a person-centered approach that combines virtual care, digital tools, connected devices and actionable data science, Newtopia delivers sustainable clinical and financial outcomes. Newtopia serves some of the largest nationwide employers and health plans and is currently listed in Canada on the Toronto Stock Exchange (TSXV:NEWU) and is quoted in the US on the OTCQB® Venture Market (OTCQB:NEWUF). To  learn more, visit newtopia.com, LinkedIn or X. Forward Looking Information This news release contains forward-looking information and forward-looking statements, within the meaning of applicable Canadian securities legislation, and forward looking statements, within the meaning of applicable United States securities legislation (collectively, "forward-looking statements"), which reflects management's expectations regarding Newtopia's future growth, results from operations (including, without limitation, future production and capital expenditures), performance (both operational and financial) and business prospects and opportunities. Wherever possible, words such as "predicts", "projects", "targets", "plans", "expects", "does not expect", "budget", "scheduled", "estimates", "forecasts", "anticipate" or "does not anticipate", "believe", "intend" and similar expressions or statements that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved, or the negative or grammatical variation thereof or other variations thereof, or comparable terminology have been used to identify forward-looking statements. All statements other than statements of historical fact may be forward-looking ‎information. Such statements reflect Newtopia's current views and intentions with respect to future ‎events, based on information available to Newtopia, and are subject to certain risks, uncertainties, and ‎assumptions. Material factors or assumptions were applied in providing forward-looking information. While forward-looking statements are based on data, assumptions and analyses that Newtopia believes are reasonable under the circumstances, whether actual results, performance or developments will meet Newtopia's expectations and predictions depends on a number of risks and uncertainties that could cause the actual results, performance and financial condition of Newtopia to differ materially from its expectations. These forward-looking statements include, among other things, statements with respect to the FFCTO, the expected filing of the Annual Filings and the completion of the audit MNP by the target date. Forward-looking statements are not a guarantee and are based on a number of estimates and assumptions management believes to be relevant and reasonable, whether actual results, performance or developments will meet Newtopia's expectations and predictions depends on a number of risks and uncertainties that could cause the actual results, performance and financial condition of Newtopia to differ materially from its expectations. Certain of the "risk factors" that could cause ‎actual results to differ materially from Newtopia's forward-looking statements in this news release ‎include, without limitation: ‎disruptions to markets, economic activity, financing, supply chains and sales channels, ‎and a ‎deterioration of general economic conditions including a possible national or global ‎recession; and other general economic, market and business conditions and factors, including the risk factors discussed or referred to in Newtopia's disclosure documents, filed with the securities ‎regulatory authorities in certain provinces of Canada and available at www.sedarplus.ca, including Newtopia's final long form prospectus dated March 30, 2020. For more information on these risks please see the "Risk Factors" in Newtopia's final long-form prospectus dated March 30, 2020. Should any factor affect Newtopia in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, Newtopia does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this news release is made as of the date of this news release, and Newtopia undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law. Preliminary Financial Metrics This news release contains certain pre-released financial metrics. The financial metrics contained in this news release are preliminary and represent the most current information available to the Company's management, as financial closing procedures for the fourth quarter and year ended December 31, 2023 are not yet complete. The Company's actual audited financial statements for such period may result in material changes to the financial metrics summarized in this news release (including by any one financial metric, or all of the financial metrics, being below or above the figures indicated) as a result of the completion of normal quarter and year end accounting procedures and adjustments, and also what one might expect to be in the final financial statements based on the financial metrics summarized in this news release. Although the Company believes the expectations reflected in this news release are based upon reasonable assumptions, the Company can give no assurance that actual results will not differ materially from these expectations. Non-GAAP Financial Measures The Company's financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS"). Management uses certain non-GAAP measures, which are defined in the appropriate sections of this press release, to better assess the Company's underlying performance. These measures are reviewed regularly by management and the Company's Board of Directors in assessing the Company's performance and in making decisions about ongoing operations. In addition, we use certain non-GAAP measures to determine the components of management compensation. We believe that these measures are also used by investors as an indicator of the Company's operating performance. Readers are cautioned that these terms are not recognized GAAP measures and do not have a standardized GAAP meaning under IFRS and should not be construed as alternatives to IFRS terms, such as net income. Neither TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release. Key Financial Measures and Schedule of Non-GAAP Reconciliations Unaudited Gross Profit Information - including amortization [1] Three Months Ended December 31, Twelve Months Ended December 31, 2023 2022 2023 2022 $ $ $ $ Revenue 2,343,249 3,114,317 9,783,546 11,166,428 Cost of revenue (1,004,225) (1,079,576) (4,505,888) (5,140,369) Gross profit 1,339,024 2,034,741 5,277,658 6,026,059 Gross profit margin 57 % 65 % 54 % 54 % Reconciliation of Total Operating Expenses to Adjusted Operating Expenses [2] Three Months Ended December 31, Twelve Months Ended December 31, 2023 2022 2023 2022 $ $ $ $ Total expenses 4,564,810 3,624,640 11,878,005 13,726,522 Add (Subtract) Share-based compensation (88,929) (88,608) (555,816) (492,720) Depreciation of property and equipment (970) (6,713) (5,935) (46,387) Loss on disposal of property and equipment - (15,534) - (15,534) Depreciation of right-of-use asset - (30,791) - (169,370) Impairment of intangible asset (2,409,314) - (2,409,314) - Impairment of right-of-use asset - (200,168) - (200,168) Lease modification - (150,907) - (150,907) Interest and accretion expense (314,174) (111,564) (908,153) (388,448) Interest on lease obligations (1,326) (10,050) (28,110) (70,797) Finance charges (132,248) (125,920) (509,238) (273,736) Amortization of deferred finance charges (42,396) (56,903) (149,896) (248,813) Foreign exchange loss (gain) (7,769) (9,945) (44,560) 19,053 Capitalized borrowing costs - - - 67,000 Debt modification 63,928 - 54,972 - Loss on settlement of related party payable (20,400) - (10,086) - Adjusted operating expenses 1,611,212 2,817,537 7,311,869 11,755,695 Adjusted Unaudited Operating Loss [3] Three Months Ended December 31, Twelve Months Ended December 31, 2023 2022 2023 2022 $ $ $ $ Gross profit 1,339,024 2,034,741 5,277,658 6,026,059 Add amortization of intangible asset 206,513 68,838 826,050 68,838 Adjusted gross profit 1,545,537 2,103,579 6,103,708 6,094,897 Adjusted operating  expenses (1,611,212) (2,817,537) (7,311,869) (11,755,695) Adjusted operating loss (65,675) (713,958) (1,208,161) (5,660,798) NEWTOPIA INC.Unaudited Statements of Financial PositionAs at December 31, 2023 and 2022(Expressed in ...